LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 79.34 | 84.90 | 58 | 9051 | 0.0064 | -0.0550 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 79.34 | 84.90 | 4802 | 9051 | 0.5305 | 0.8204 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 79.34 | 84.90 | 141 | 9051 | 0.0156 | 0.0782 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 79.34 | 84.90 | 3657 | 9051 | 0.4040 | 0.7482 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 79.34 | 84.90 | 4745 | 9051 | 0.5242 | 0.8172 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 79.34 | 84.90 | 4882 | 9051 | 0.5394 | 0.8249 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 81.05 | 84.90 | 46 | 8863 | 0.0052 | -0.0873 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 81.05 | 84.90 | 4934 | 8863 | 0.5566 | 0.8327 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 81.05 | 84.90 | 136 | 8863 | 0.0153 | 0.0728 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 81.05 | 84.90 | 3760 | 8863 | 0.4242 | 0.7599 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 81.05 | 84.90 | 4814 | 8863 | 0.5431 | 0.8260 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 81.05 | 84.90 | 4995 | 8863 | 0.5635 | 0.8361 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 82.75 | 84.90 | 36 | 8621 | 0.0042 | -0.1208 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 82.75 | 84.90 | 5084 | 8621 | 0.5897 | 0.8477 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 82.75 | 84.90 | 146 | 8621 | 0.0169 | 0.0847 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 82.75 | 84.90 | 3862 | 8621 | 0.4480 | 0.7730 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 82.75 | 84.90 | 4945 | 8621 | 0.5736 | 0.8400 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 82.75 | 84.90 | 5078 | 8621 | 0.5890 | 0.8473 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 84.45 | 84.90 | 37 | 8254 | 0.0045 | -0.1182 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 84.45 | 84.90 | 5240 | 8254 | 0.6348 | 0.8670 | MN20160318_Q02 | H19 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 84.45 | 84.90 | 116 | 8254 | 0.0141 | 0.0484 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 84.45 | 84.90 | 3887 | 8254 | 0.4709 | 0.7844 | MN20160318_Q02 | H20 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 84.45 | 84.90 | 5079 | 8254 | 0.6153 | 0.8582 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 84.45 | 84.90 | 5209 | 8254 | 0.6310 | 0.8653 | MN20160318_Q02 | K06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 86.16 | 84.90 | 63 | 8141 | 0.0077 | -0.0443 | MN20160318_Q02 | H19 |